Bevespi Aerosphere

Generic name: Formoterol And Glycopyrrolate
Drug class: Bronchodilator combinations

Usage of Bevespi Aerosphere

Bevespi Aerosphere is an inhalation aerosol containing a combination of formoterol and glycopyrrolate. Formoterol is a bronchodilator. Glycopyrrolate is an anticholinergic. These medications work by relaxing muscles in the airways to improve breathing.

Bevespi Aerosphere is used to prevent airflow obstruction or bronchospasm and reduce flare-ups in adults with COPD (chronic obstructive pulmonary disease), including bronchitis and emphysema.

Bevespi Aerosphere is not for use in treating asthma.

Formoterol may increase the risk of death in people with asthma, but the risk in people with COPD is not known. Talk with your doctor about your individual risk.

Bevespi Aerosphere side effects

Get emergency medical help if you have signs of an allergic reaction to Bevespi: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have:

tremors, nervousness, chest pain, fast or pounding heartbeats;

wheezing, choking, or other breathing problems after using this medicine;

painful or difficult urination;

blurred vision, tunnel vision, eye pain or redness, or seeing halos around lights;

high blood sugar - increased thirst, increased urination, dry mouth, fruity breath odor; or

low potassium level - leg cramps, constipation, irregular heartbeats, fluttering in your chest, numbness or tingling, muscle weakness or limp feeling.

Common Bevespi side effects may include:

cough; or

urination problems.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Bevespi Aerosphere

You should not use Bevespi Aerosphere if you are allergic to formoterol or glycopyrrolate. This medicine is for use only in people with COPD and should not be used to treat asthma.

To make sure Bevespi Aerosphere is safe for you, tell your doctor if you have ever had:

heart disease, high blood pressure;

a seizure;

liver disease;

glaucoma;

diabetes;

a thyroid disorder;

urination problems; or

any food or drug allergies.

Tell your doctor if you are pregnant or breastfeeding.

This medicine is not approved for use by anyone younger than 18 years old.

Relate drugs

How to use Bevespi Aerosphere

Usual Adult Dose for Chronic Obstructive Pulmonary Disease -- Maintenance:

2 inhalations orally twice a day, in the morning and in the evening Maximum dose: 2 inhalations twice daily Comments: -Two inhalations of formoterol 4.8 mcg-glycopyrrolate 9 mcg equal one dose. Uses: Long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema

Warnings

Bevespi Aerosphere is for use only in people with chronic obstructive pulmonary disease (COPD) and should not be used to treat asthma.

Bevespi Aerosphere is not a rescue medicine. It will not work fast enough to treat a bronchospasm attack.

Seek medical attention if your breathing problems get worse quickly, or if you think your medications are not working as well.

What other drugs will affect Bevespi Aerosphere

Tell your doctor about all your other medicines, especially:

atropine;

antifungal or antiviral medicine;

medicine to treat depression, anxiety, mood disorders, or mental illness;

cold or allergy medicine (Benadryl and others);

medicine to treat Parkinson's disease;

medicine to treat stomach problems, motion sickness, or irritable bowel syndrome;

medicine to treat overactive bladder; or

other bronchodilator medication.

This list is not complete. Other drugs may interact with formoterol and glycopyrrolate, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

Popular FAQ

Bevespi Aerosphere can be used with a spacer device if recommended by your doctor. The method of using a metered-dose inhaler can be challenging for some patients making inhalation difficult. A spacer device can help to deliver the medicine more easily to your lungs. If you are having trouble inhaling your medicine, contact your doctor to discuss the use of a spacer device. Continue reading

Bevespi Aerosphere aerosol inhaler contains either 120 or 28 inhalations (puffs) depending up the size of the inhaler you receive. Your canister will last 30 days (with the 120 count inhaler) or 7 days (with the 28 count inhaler). Continue reading

You may notice some improvement in your breathing within minutes to hours after using Bevespi Aerosphere (formoterol fumarate and glycopyrrolate), but it is considered a long-term, inhaled maintenance treatment for chronic obstructive pulmonary disease (COPD). Bevespi Aerosphere is not used to treat sudden breathing problems. Use a fast-acting rescue inhaler such as albuterol for sudden breathing problems. Continue reading

Bevespi Aerosphere is a metered dose inhaler (MDI) handheld canister that gives you your medicine as an inhaled mist. Bevespi Aerosphere delivers 9 micrograms (mcg) of glycopyrrolate and 4.8 mcg of formoterol fumarate per inhalation for the long-term treatment of chronic obstructive pulmonary disease (COPD). It is not used as a fast-acting (rescue) inhaler. Continue reading

Bevespi Aerosphere is normally given as 2 inhalations twice a day for COPD, in the morning and in the evening, via a pressurized metered dose inhaler. Follow the illustrated instructions enclosed with your inhaler, and if you have questions, ask your pharmacist or doctor. Your healthcare provider can show you how to use the inhaler. Continue reading

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.